Zobrazeno 1 - 10
of 139
pro vyhledávání: '"Saiko Kurosawa"'
Publikováno v:
Drugs in Context, Vol 8, Pp 1-14 (2019)
B-cell non-Hodgkin lymphoma (NHL) is the most frequent hematologic malignancy. Despite the refinement of chemoimmunotherapy, a substantial number of patients experience chemorefractory disease. Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy
Externí odkaz:
https://doaj.org/article/cc7cf8f6699b4c228c3cae9866862600
Autor:
Shigeo Fuji, Takuhiro Yamaguchi, Yoshitaka Inoue, Atae Utsunomiya, Yukiyoshi Moriuchi, Kaoru Uchimaru, Satsuki Owatari, Takashi Miyagi, Jun Taguchi, Ilseung Choi, Eiichi Otsuka, Sawako Nakachi, Hisashi Yamamoto, Saiko Kurosawa, Kensei Tobinai, Takahiro Fukuda
Publikováno v:
Haematologica, Vol 102, Iss 7 (2017)
Adult T-cell leukemia-lymphoma is a distinct type of peripheral T-cell lymphoma caused by human T-cell lymphotropic virus type I. Although allogeneic stem cell transplantation after chemotherapy is a recommended treatment option for patients with agg
Externí odkaz:
https://doaj.org/article/339d835293fe4bc5afadb06afeb94173
Autor:
Takeshi Ryotokuji, Hiroki Yamaguchi, Toshimitsu Ueki, Kensuke Usuki, Saiko Kurosawa, Yutaka Kobayashi, Eri Kawata, Kenji Tajika, Seiji Gomi, Junya Kanda, Anna Kobayashi, Ikuko Omori, Atsushi Marumo, Yusuke Fujiwara, Shunsuke Yui, Kazuki Terada, Keiko Fukunaga, Tsuneaki Hirakawa, Kunihito Arai, Tomoaki Kitano, Fumiko Kosaka, Hayato Tamai, Kazutaka Nakayama, Satoshi Wakita, Takahiro Fukuda, Koiti Inokuchi
Publikováno v:
Haematologica, Vol 101, Iss 9 (2016)
In recent years, it has been reported that the frequency of DNA-methylation regulatory gene mutations – mutations of the genes that regulate gene expression through DNA methylation – is high in acute myeloid leukemia. The objective of the present
Externí odkaz:
https://doaj.org/article/cb880013303b4206a27de053b4357c0a
Autor:
Saiko Kurosawa, Shuichi Miyawaki, Takuhiro Yamaguchi, Heiwa Kanamori, Toru Sakura, Yukiyoshi Moriuchi, Fumiaki Sano, Takeshi Kobayashi, Atsushi Yasumoto, Kazuo Hatanaka, Masamitsu Yanada, Yuichiro Nawa, Jin Takeuchi, Yukinori Nakamura, Shin Fujisawa, Hirohiko Shibayama, Ikuo Miura, Takahiro Fukuda
Publikováno v:
Haematologica, Vol 98, Iss 10 (2013)
Core binding factor acute myeloid leukemia is known to have a favorable prognosis, however, there have been no detailed analyses on prognostic factors after first relapse. Using a nationwide database, we retrospectively analyzed core binding factor a
Externí odkaz:
https://doaj.org/article/4fce2915197c4bc7b218045aed1ad13a
Autor:
Masamitsu Yanada, Saiko Kurosawa, Takuhiro Yamaguchi, Takuya Yamashita, Yukiyoshi Moriuchi, Hiroatsu Ago, Jin Takeuchi, Hirohisa Nakamae, Jun Taguchi, Toru Sakura, Yasushi Takamatsu, Fusako Waki, Hiroki Yokoyama, Masato Watanabe, Nobuhiko Emi, Takahiro Fukuda
Publikováno v:
Haematologica, Vol 97, Iss 6 (2012)
To evaluate the prognostic impact of monosomal karyotype on post-remission outcome in acute myeloid leukemia, we retrospectively analyzed 2,099 patients who had achieved complete remission. Monosomal karyotype was noted in 73 patients (4%). Of these,
Externí odkaz:
https://doaj.org/article/00d5db78d75f4be993138f6bb3fd79d1
Autor:
Saiko Kurosawa, Takuhiro Yamaguchi, Shuichi Miyawaki, Naoyuki Uchida, Toru Sakura, Heiwa Kanamori, Kensuke Usuki, Takuya Yamashita, Yasushi Okoshi, Hirohiko Shibayama, Hirohisa Nakamae, Momoko Mawatari, Kazuo Hatanaka, Kazutaka Sunami, Manabu Shimoyama, Naohito Fujishima, Yoshinobu Maeda, Ikuo Miura, Yoichi Takaue, Takahiro Fukuda
Publikováno v:
Haematologica, Vol 95, Iss 11 (2010)
Background Patients with acute myeloid leukemia who are treated with conventional chemotherapy still have a substantial risk of relapse; the prognostic factors and optimal treatments after relapse have not been fully established. We, therefore, retro
Externí odkaz:
https://doaj.org/article/2b4b19720230449bba867998468f4a6d
Autor:
Keiji, Okinaka, Yukihiro, Akeda, Yoshihiro, Inamoto, Shigeo, Fuji, Ayumu, Ito, Takashi, Tanaka, Saiko, Kurosawa, Sung-Won, Kim, Ryuji, Tanosaki, Takuya, Yamashita, Chikako, Ohwada, Keiji, Kurata, Takeshi, Mori, Masahiro, Onozawa, Kuniko, Takano, Hiroki, Yokoyama, Katsuyoshi, Koh, Koji, Nagafuji, Kazutaka, Nakayama, Toru, Sakura, Tsutomu, Takahashi, Kazunori, Oishi, Takahiro, Fukuda
Publikováno v:
Clinical Microbiology and Infection. 29:482-489
This multicentre, phase 2, randomized, controlled study of allogeneic haematopoietic stem cell transplantation (allo-HSCT) recipients compared the immunogenicity of two anti-pneumococcal vaccine regimens: four doses of 13-valent pneumococcal conjugat
Autor:
Satoshi Wakita, Atsushi Marumo, Kaoru Morita, Shinichi Kako, Takashi Toya, Yuho Najima, Noriko Doki, Junya Kanda, Junya Kuroda, Shinichiro Mori, Atsushi Satake, Kensuke Usuki, Toshimitsu Ueki, Nobuhiko Uoshima, Yutaka Kobayashi, Eri Kawata, Kazutaka Nakayama, Yuhei Nagao, Katsuhiro Shono, Motoharu Shibusawa, Jiro Tadokoro, Masao Hagihara, Hitoji Uchiyama, Naoyuki Uchida, Yasushi Kubota, Shinya Kimura, Hisao Nagoshi, Tatsuo Ichinohe, Saiko Kurosawa, Sayuri Motomura, Akiko Hashimoto, Hideharu Muto, Eriko Sato, Masao Ogata, Kenjiro Mitsuhashi, Jun Ando, Haruko Tashiro, Masahiro Sakaguchi, Shunsuke Yui, Kunihito Arai, Tomoaki Kitano, Miho Miyata, Haruka Arai, Masayuki Kanda, Kako Itabashi, Takahiro Fukuda, Yoshinobu Kanda, Hiroki Yamaguchi
Publikováno v:
Cancer Science. 114:1297-1308
Nucleophosmin1 (NPM1) mutations are the most frequently detected gene mutations in acute myeloid leukemia (AML) and are considered a favorable prognostic factor. We retrospectively analyzed the prognosis of 605 Japanese patients with de novo AML, inc
Autor:
Saiko Kurosawa
Publikováno v:
Japanese Journal of Transplantation and Cellular Therapy. 12:18-28
Autor:
Saiko Kurosawa, Takuhiro Yamaguchi, Ayako Mori, Tomoko Matsuura, Masayoshi Masuko, Makoto Murata, Haruko Tashiro, Shinichi Kako, Atsushi Satake, Maki Hagihara, Shuichi Ota, Takeshi Saito, Kumiko Kagawa, Yayoi Matsuo, Hidehiro Itonaga, Nobuhiko Uoshima, Hiroki Yamaguchi, Kensuke Naito, Miyako Takahashi, Takahiro Fukuda
Publikováno v:
Journal of Cancer Survivorship. 17:781-794
Although rather favorable probabilities of return to work have been reported after allogeneic hematopoietic cell transplantation (allo-HCT), survivors often have difficulty continuing to work because of their immunocompromised status and diverse late